search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Mohamed Amgad ,
Elisabeth Specht Stovgaard ,
Eva Balslev ,
Jeppe Thagaard ,
Weijie Chen ,
Sarah Dudgeon ,
Ashish Sharma ,
Jennifer K Kerner ,
Carsten Denkert ,
Yinyin Yuan ,
Khalid AbdulJabbar ,
Stephan Wienert ,
Peter Savas ,
Leonie Voorwerk ,
Andrew H Beck ,
Anant Madabhushi ,
Johan Hartman ,
Manu M Sebastian ,
Hugo M Horlings ,
Jan Hudeček ,
Francesco Ciompi ,
David A Moore ,
Rajendra Singh ,
Elvire Roblin ,
Marcelo Luiz Balancin ,
Marie-Christine Mathieu ,
Jochen K Lennerz ,
Pawan Kirtani ,
I-Chun Chen ,
Jeremy P Braybrooke ,
Giancarlo Pruneri ,
Sandra Demaria ,
Sylvia Adams ,
Stuart J Schnitt ,
Sunil R Lakhani ,
Federico Rojo ,
Laura Comerma ,
Sunil S Badve ,
Mehrnoush Khojasteh ,
W Fraser Symmans ,
Christos Sotiriou ,
Paula Gonzalez-Ericsson ,
Katherine L Pogue-Geile ,
Rim S Kim ,
David L Rimm ,
Giuseppe Viale ,
Stephen M Hewitt ,
John M S Bartlett ,
Frédérique Penault-Llorca ,
Shom Goel ,
Huang-Chun Lien ,
Sibylle Loibl ,
Zuzana Kos ,
Sherene Loi ,
Matthew G Hanna ,
Stefan Michiels ,
Marleen Kok ,
Torsten O Nielsen ,
Alexander J Lazar ,
Zsuzsanna Bago-Horvath ,
Loes F S Kooreman ,
Jeroen A W M van der Laak ,
Joel Saltz ,
Brandon D Gallas ,
Uday Kurkure ,
Michael Barnes ,
Roberto Salgado ,
Lee A D Cooper ,

Abstract

Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer, as well as many other solid tumors. This recognition has come about thanks to standardized visual reporting guidelines, which helped to reduce inter-reader variability. Now, there are ripe opportunities to employ computational methods that extract spatio-morphologic predictive features, enabling computer-aided diagnostics. We detail the benefits of computational TILs assessment, the readiness of TILs scoring for computational assessment, and outline considerations for overcoming key barriers to clinical translation in this arena. Specifically, we discuss: 1. ensuring computational workflows closely capture visual guidelines and standards; 2. challenges and thoughts standards for assessment of algorithms including training, preanalytical, analytical, and clinical validation; 3. perspectives on how to realize the potential of machine learning models and to overcome the perceptual and practical limits of visual scoring.

More about this publication

NPJ breast cancer

Volume 6
Pages 16
Publication date 16-05-2020

Full text links

Publisher website (DOI) 10.1038/s41523-020-0154-2
Europe PubMed Central 32411818
Pubmed 32411818

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.